BDNF Val66Met polymorphism influence on striatal blood-level-dependent response to monetary feedback depends on valence and agency  by Chumbley, J. et al.
Neuroscience 280 (2014) 130–141BDNF VAL66MET POLYMORPHISM INFLUENCE ON STRIATAL
BLOOD-LEVEL-DEPENDENT RESPONSE TO MONETARY FEEDBACK
DEPENDS ON VALENCE AND AGENCYJ. CHUMBLEY, a J. SPA¨TI, b N. DO¨RIG, c,d J. BRAKOWSKI, e
M. GROSSE HOLTFORTH, c,f E. SEIFRITZ d,e,g AND
S. SPINELLI d,g,h*
a Laboratory for Social and Neural Systems Research, Department
of Economics, University of Zurich, Switzerland
bDepartment of Psychophysiology, National Institute of Mental
Health, National Center of Neurology and Psychiatry, Tokyo, Japan
cDepartment of Psychology, University of Zurich, Switzerland
dNeuroscience Center, University and ETH Zurich, Switzerland
eDepartment of Psychiatry, Psychotherapy and Psychosomatics,
Hospital of Psychiatry, University of Zurich, Switzerland
fDepartment of Psychology, University of Bern, Switzerland
gZurich Center for Integrative Human Physiology, University
of Zurich, Switzerland
hPreclinical Laboratory for Translational Research into
Aﬀective Disorders, Department of Psychiatry, Psychotherapy
and Psychosomatics, Hospital of Psychiatry, University of
Zurich, SwitzerlandAbstract—Animal work implicates the brain-derived neuro-
trophic factor (BDNF) in function of the ventral striatum
(VS), a region known for its role in processing valenced
feedback. Recent evidence in humans shows that BDNF
Val66Met polymorphism modulates VS activity in anticipa-
tion of monetary feedback. However, it remains unclear
whether the polymorphism impacts the processing of self-
attributed feedback diﬀerently from feedback attributed to
an external agent. In this study, we emphasize the impor-
tance of the feedback attribution because agency is central
to computational accounts of the striatum and cognitive
accounts of valence processing. We used functional mag-
netic resonance imaging and a task, in which ﬁnancial
gains/losses are either attributable to performance (self-
attributed, SA) or chance (externally-attributed, EA) to ask
whether BDNF Val66Met polymorphism predicts VS activity.http://dx.doi.org/10.1016/j.neuroscience.2014.09.014
0306-4522/ 2014 The Authors. Published by Elsevier Ltd. on behalf of IBRO.
This is an open access article under the CC BY-NC-ND license (http://creativecomm
*Correspondence to: S. Spinelli, Preclinical Laboratory for Transla-
tional Research into Aﬀective Disorders, Department of Psychiatry,
Psychotherapy and Psychosomatics, Hospital of Psychiatry, Univer-
sity of Zurich, August Forel-Strasse 7, CH-8008 Zurich, Switzerland.
Tel: +41-44-634-8923.
E-mail address: spinellisimona@gmail.com (S. Spinelli).
Abbreviations: ADS, General Depression Scale; BAS, Behavioral
Activation System; BDNF, Brain-derived neurotrophic factor; BFI,
Big-Five inventory; BIS, Behavioral Inhibition System; BOLD, blood-
level-dependent; EA, externally-attributed; FWE, family-wise error; IFJ,
inferior frontal junction; MDD, major depressive disorder; MNI,
Montreal Neurological Institute; PSS, Perceived Stress Scale;
RM-ANOVA, repeated-measures analyses of variance; RT, reaction
time; SA, self-attributed; STAI, State-Trait Anxiety Inventory; VS,
ventral striatum.
130We found that BDNF Val66Met polymorphism inﬂuenced
how feedback valence and agency information were com-
bined in the VS and in the right inferior frontal junction
(IFJ). Speciﬁcally, Met carriers’ VS response to valenced
feedback depended on agency information, while Val/Val
carriers’ VS response did not. This context-speciﬁc modula-
tion of valence eﬀectively ampliﬁed VS responses to SA
losses in Met carriers. The IFJ response to SA losses also
diﬀerentiated Val/Val from Met carriers. These results may
point to a reduced allocation of attention and altered motiva-
tional salience to SA losses in Val/Val compared to Met car-
riers. Implications for major depressive disorder are
discussed.  2014 The Authors. Published by Elsevier Ltd.
on behalf of IBRO. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/3.0/).
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The brain-derived neurotrophic factor (BDNF) is a
prevalent growth factor in the central nervous system,
which is important for synaptic plasticity and neuronal
survival throughout life (Poo, 2001). One common func-
tional variant of the BDNF gene is the single-nucleotide
polymorphism rs 6265, which results in a valine to methio-
nine substitution at codon 66 (Val66Met) of the precursor
protein pro-BDNF. This single-nucleotide polymorphism
alters intracellular traﬃcking and secretion of the mature
BDNF: Carriers of the Met allele show reduced activity-
dependent secretion of BDNF compared to Val/Val homo-
zygotes (Egan et al., 2003; Chen et al., 2004).
BDNF Val66Met polymorphism predicts cognitive
performance as well as brain structure in healthy
subjects (Chen et al., 2008; Dincheva et al., 2012), but
these genotype diﬀerences have a complex proﬁle. Com-
pared to Val/Val subjects, Met carriers show poorer per-
formance in hippocampal-dependent memory tasks
(Egan et al., 2003; Hariri et al., 2003; Schoﬁeld et al.,
2009) and reduced hippocampal gray matter volume
(Pezawas et al., 2004; Bueller et al., 2006; Frodl et al.,
2007), but improved response inhibition and interference
resolution (Beste et al., 2010a; Gajewski et al., 2012).
These ﬁndings appear to tie Met carriers’ deﬁcits to
fronto-hippocampal function (Schoﬁeld et al., 2009),ons.org/licenses/by-nc-nd/3.0/).
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to-striatal function (Beste et al., 2010a; Gajewski et al.,
2012; Getzmann et al., 2013). Animal studies also point
to a dissociation of BDNF’s eﬀect on diﬀerent neural cir-
cuits depending on direction and location of manipula-
tions: Increasing BDNF in the hippocampus promotes
hippocampal-dependent learning (Peters et al., 2010),
whereas decreasing BDNF in the ventral tegmental area
promotes reward sensitivity and presumably reward
learning (Koo et al., 2012). Moreover, depressive-like
behaviors induced by chronic exposure to stressors are
related to lower BDNF levels in the hippocampus, but
higher BDNF levels in the ventral tegmental area and
the nucleus accumbens [(Berton et al., 2006; Krishnan
et al., 2007); see also (Yu and Chen, 2011)].
Such functional dissociations may obscure our
understanding of the human BDNF Val66Met
polymorphism both in healthy subjects and patients with
neuropsychiatric disorders, including major depressive
disorder (MDD) (Autry and Monteggia, 2012). Hippocam-
pal structure and function in healthyMet carriers resemble
that of depressed patients (Hariri et al., 2003; Gatt et al.,
2007, 2008). Additionally, exposure to early-life stress, a
known contributing factor to MDD, has been shown to pre-
dict higher syndromal depression through loss of hippo-
campus and prefrontal gray matter in Met carriers (Gatt
et al., 2009). These ﬁndings strongly suggest that the
Met allele may increase vulnerability to MDD by aﬀecting
hippocampal-related functions. The association between
the Met allele and MDD (Hwang et al., 2006), however,
has not been consistently replicated (Verhagen et al.,
2010; Lee et al., 2014). Furthermore, there are reasons
to expect increased vulnerability among Val/Val carriers:
Trait anxiety and neuroticism are risk factors for MDD that
are reportedly higher in Val/Val rather than Met carriers
(Sen et al., 2003; Lang et al., 2005; Hunnerkopf et al.,
2007; Frustaci et al., 2008). Given the apparent inconsis-
tencies detailed above, it seems plausible that BDNF
Val66Met polymorphism may impact risk for MDD through
diﬀerent, allele-speciﬁc, neurocognitive systems (Gatt
et al., 2009; Gottfredson et al., 2014).
The ventral striatum (VS) plays a key role in the
processing of valenced outcomes [e.g.(Ullsperger and
von Cramon, 2003; Studer et al., 2012)] and altered VS
response to feedback has been widely reported in MDD
(Eshel and Roiser, 2010). Recent evidence shows that
BDNF Val66Met polymorphism modulates activity in the
VS and the ventral tegmental area in anticipation of mon-
etary losses (Pecina et al., 2014). Moreover, the polymor-
phism has been shown to inﬂuence brain activity in
response to errors (Beste et al., 2010b), as well as to
the passive presentation of pleasant and aversive stimuli
(Montag et al., 2008; Gasic et al., 2009). However, it
remains unclear whether the polymorphism impacts
responses to self-attributed feedback diﬀerently from
externally-attributed feedback. Because agency is central
to computational accounts of the striatum (Dayan and Niv,
2008) and of cognitive accounts of valence processing
(Weiner, 2010), we investigated whether genotype
predicted the magnitude of the blood-level-dependent
(BOLD) responses to ﬁnancial gains and losses arisingeither by chance (externally-attributed outcomes, EA) or
due to subjects’ performance (self-attributed outcomes,
SA) (Spa¨ti et al., 2014). We had three hypotheses. First,
we hypothesized that BDNF Val66Met polymorphism
inﬂuences striatal encoding of causal information about
rewards and punishments. More speciﬁcally, we hypothe-
sized that information about valence and causal attribu-
tion would be combined diﬀerentially between
genotypes. Second, we hypothesized that these diﬀer-
ences may reduce to genotype-speciﬁc striatal prediction
errors. Third, because individual diﬀerences in reward
sensitivity (measured by the Behavioral Activation Scale)
have been found to shape behavioral responses to incen-
tive stimuli (Pickering and Gray, 2001), as well as VS
responses to such stimuli (Beaver et al., 2006; Simon
et al., 2010), we expected individual reward sensitivity to
predict VS responses to ﬁnancial feedback.EXPERIMENTAL PROCEDURES
Participants
Thirty-ﬁve unrelated healthy Caucasians without any
reported psychiatric, neurologic or medical illness (as
conﬁrmed by a Structured Clinical Interview for Axis I
Disorders) between the age of 20 and 59 years were
included in the study. As reported below, individuals
who were homozygous for the Met allele were merged
with the heterozygous individuals into a group of Met
carriers (n= 18) and compared to homozygous Val
carriers (n= 17). Groups were matched for age,
gender, years of education, psychometric measures and
task’s performance (see Table 1).
The study was approved by the University of Zurich’s
Institutional Review Board, and all subjects gave written
informed consent.Psychometric measures
All participants completed the German version of the
Action Regulating Emotion Systems scale [ARES,
(Hartig and Moosbrugger, 2003)], which provides Behav-
ioral Inhibition System (BIS) and Behavioral Activation
System (BAS) scores reﬂecting, respectively, punishment
and reward sensitivity. BIS and BAS are composed of two
subscores: Anxiety/frustration and drive/gratiﬁcation,
respectively. In addition, participants completed the short
version of the Big-Five inventory [BFI, (Rammstedt and
John, 2005)], which provided ﬁve personality measures,
including neuroticism, extraversion, openness, conscien-
tiousness and agreeableness; the General Depression
Scale [ADS, Allgemeine Depressionsskala (Hautzinger
and Bailer, 1993)]; the State-Trait Anxiety Inventory
[STAI, (Laux et al., 1981)] and the Perceived Stress Scale
(PSS, (Cohen et al., 1983)].Motion prediction task
The motion prediction task has been previously described
in detail (Spa¨ti et al., 2014). In brief, each trial started with
two balls moving, at diﬀerent speeds and from diﬀerent
starting positions, toward a ﬁnish line. The task was to
Table 1. Demographic, psychometric and behavioral information
Met carriers
N= 18
Val/Val carriers
N = 17
Statistic
Gender (%) 8 females (44%) 10 females (59%) n.s
Age (mean ± SD) 32.7 ± 13.1 29.7 ± 8.5 n.s
Years of education 15.5 ± 2.7 15.7 ± 2.4 n.s
Left-handed 1 1
STAI-T (mean ± SD) 32.2 ± 8.6 34.8 ± 7.3 n.s
ADS-Scale (mean ± SD) 5.2 ± 4.0 4.8 ± 4.1 n.s
BFI-neuroticism (mean ± SD) 9.7 ± 3.2 10.7 ± 2.7 n.s
PSS (mean ± SD) 30.8 ± 6.3 33.1 ± 9.1 n.s
BIS anxiety (mean ± SD) 10.9 ± 3.5 11.1 ± 2.7 n.s
BIS frustration (mean ± SD) 11.5 ± 5.8 10.8 ± 2.9 n.s
BAS drive (mean ± SD) 17.2 ± 2.0 17.4 ± 1.7 n.s
BAS gratiﬁcation (mean ± SD) 17.6 ± 2.3 17.7 ± 1.9 n.s
% SA gains (mean ± SD) 59.5 ± 5.4 60.0 ± 6.3 n.s
% EA gains (mean ± SD) 58.2 ± 8.3 59.8 ± 6.2 n.s
% Miss (mean ± SD) 1.0 ± 1.6 0.5 ± 0.7 n.s
RT correct (mean ± SD) 487.9 ± 90.6 523.4 ± 156.9 n.s
RT incorrect (mean ± SD) 524.4 ± 87.6 551.0 ± 165.7 n.s
RT post-SA losses (mean ± SD) 513.6 ± 11.7 533.1 ± 161.2 n.s
RT post-SA gains (mean ± SD) 497.8 ± 89.5 528.7 ± 172.1 n.s
RT post-EA losses (mean ± SD) 489.1 ± 87.6 517.8 ± 154.3 n.s
RT post-EA gains (mean ± SD) 490.8 ± 91.6 517.5 ± 157.7 n.s
STAI-T, Spielberger Trait Anxiety Inventory; ADS, General Depression Scale; BFI-Neuroticism, Short version of the Big Five Inventory-
Neuroticism score; PSS, Perceived Stress Scale; BIS, Behavioral Inhibition System; BAS, Behavioral Approach System; SA, self-attributed;
EA, externally-attributed; RT, reaction time (ms); n.s, not signiﬁcant.
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indicate the decision by a left or right button press, using
the left or right hand, respectively. Only after the response
was made, subjects were instructed whether their
response was relevant or irrelevant to the upcoming feed-
back. Speciﬁcally, subjects were told that on each trial
they would gain or lose 50 cents indicated by a ‘‘+50’’
or ‘‘50’’ feedback. At random 50% of the trials feedback
was performance-dependent (SA). The other 50% of trials
feedback was dependent on chance, being randomly
selected by the computer (EA). 750 ms after the
response, the words ‘‘You’’ and ‘‘Coin’’ and an arrow
pointing toward either word was presented to indicate
whether the upcoming feedback depended on the sub-
ject’s performance or not. Finally, feedback about winning
(+50) or losing (50) was presented. The next trial
started after 2000 ± 500 ms, which provided some jitter-
ing between trials. If the subject failed to respond, the
arrow pointed toward the word ‘‘You’’ followed by the
feedback ‘‘Missed’’. To keep uncertainty about perfor-
mance high during the functional magnetic resonance
imaging (fMRI) paradigm, task diﬃculty was adapted for
each participant such that none of the participants had
an error rate lower than 30%. The average error rate
was around 40%. Prior to the task, diﬃculty levels were
individually determined based on a training session of
100 trials performed during the anatomical scans, during
which subjects received only a performance feedback
(correct: smiley face, incorrect: unhappy face). Partici-
pants were unaware that the diﬃculty of the task was
manipulated; they were told to do their best at winning
and were paid based on performance plus a modest
compensation for participating in the study. Three Met
and one Val/Val carrier performed a shorter version ofthe task of 100 trials, all other subjects completed 130 tri-
als. The chance of monetary gain for EA and SA feedback
was around 60% and similar across genotypes (Table 1).Image acquisition
Images were acquired on a Philips Achieva TX 3T whole-
body MR unit equipped with an eight-channel head coil.
Functional time series were acquired with a sensitivity-
encoded single-shot echo-planar sequence (echo
time = 35 ms, 80  80 voxel matrix, interpolated to
128  128, voxel size: 2.75  2.75  4 mm3, SENSE
acceleration factor R= 2.0). Thirty-six contiguous axial
slices were placed along the anterior-posterior
commissure plane covering the entire brain and acquired
in ascending order (repetition time = 2000 ms). The ﬁrst
four acquisitions were discarded due to T1 saturation
eﬀects. T1-weighted high-resolution images were also
acquired for each participant.Data analysis
Demographic, psychometric, and behavioral data were
analyzed with unpaired t-tests and gender with the
Chi-squared test using StatView 5.0.1 (SAS Institute,
Inc., Cary, NC, USA) with the signiﬁcance level of 0.05
(two-tailed). Mean reaction time (RT) diﬀerences for
correct and incorrect trials were analyzed with repeated-
measures analyses of variance (RM-ANOVA) with
reaction time for incorrect and correct trials as within-
subject factors, and genotypes (Met and Val/Val) as
independent factors.
In order to correctly attribute gains/losses on each trial,
participants must attend to and discriminate the two
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whether genotypes diﬀered in this basic capacity to
discriminate. We therefore compared the two genotypes
on ‘post-SA slowing’, a behavioral measure of
discrimination. Post-SA feedback slowing refers to longer
RT in trials following a SA feedback relative to EA
feedback, and is found in healthy subjects (Spa¨ti et al.,
2014). We made this genotype comparison via
RM-ANOVA.
Image processing was carried out using MATLAB
R2012a (The Mathworks, Natick, MA, USA) and
Statistical Parametric Mapping (SPM8; Wellcome
Department of Imaging Neuroscience, London, UK; http://
www.ﬁl.ion.ucl.ac.uk). The preprocessing is described in
detail in Spa¨ti et al. (2014). In brief, functional images pre-
processing included motion correction, coregistration to a
standard template, alignment to the ﬁrst volume for each
subject, spatial normalization to the Montreal Neurological
Institute (MNI) template, and smoothing using a Gaussian-
kernel ﬁlterwith a full-width-at-half-maximumof 8-mm. Sta-
tistical analysis was performed by modeling the diﬀerent
conditions convolved with a hemodynamic response func-
tion and its temporal derivative as explanatory variables
within the context of the general linear model on a voxel-
by-voxel basis.
The 2  2 factorial design independently manipulated
the agency and valence of feedback. Several regressors
were modeled as events, including the four feedback
conditions (SA losses, EA losses, SA gains, EA gains),
the regressors of no interest [the missed feedback, theTable 2. Brain activity associated with BDNF Val66Met polymorphism on the
Cluster (voxels) T (peak) p Cluster-level Region
(SA gains vs EA gains) > (SA losses vs EA losses)
Met
251 8.23 <0.003 Cauda
Putame
1082 7.34 <0.001 Parace
Parace
Precun
149 5.85 <0.03 Inferior
Inferior
Cerebe
Val/Val
139 6.07 <0.04 Middle
125 5.94 <0.05 Angula
Middle
228 5.70 <0.004 Angula
Angula
Met > Val/Val
None
Val/Val > Met
None
(SA losses vs EA losses) > (SA gains vs EA gains)
Met
None
Val/Val
None
Met > Val/Val
305 5.66 <0.003 Precen
Val/Val > Met
None
G, gyrus; Hem, hemisphere; L, left; R, right.motor response (button press), and the realignment
parameters [see also (Spa¨ti et al., 2014)]]. The other sub-
components of the trial (ﬁxation, ball motion, attribution
assignment) were not explicitly modeled with separate
regressors. Because our mean reaction time for incorrect
trials was signiﬁcantly longer than for correct trials (see
Results), we included reaction time as a ﬁrst-order para-
metric modulator. Subject-speciﬁc analyses provided con-
trast images which were then submitted to a second-level
random eﬀects analysis to examine genotype diﬀerences,
using two-sample t-tests with age and gender as covari-
ates. Unless otherwise speciﬁed, clusters of activation
were identiﬁed with a global height threshold of
p< 0.001 uncorrected and family-wise error (FWE) cor-
rected for multiple comparison to achieve a statistical
threshold of p< 0.05. Regions were anatomically labeled
using the automatic anatomical labeling (aal) from theSPM
toolbox and by visual inspection; the mean percent signal
change across all the voxels in a functional cluster was cal-
culated usingmarsbar. A VSmask, deﬁned as two spheres
ofØ 14-mmcentered in the ventral putamen at coordinates
x=±20, y= 12, z= 14 according to our previous ﬁnd-
ings (Spa¨ti et al., 2014), was created using wfu-pickatlas.
Coordinates are reported in MNI space.Model-based prediction error analysis
We also considered an augmented model with four
additional predictors. Speciﬁcally, for each cell of the
agency by valence factorial design, we included avalence  attribution interaction
x y z Hem
te 14 14 10 R
n 22 14 14 R
ntral lobule 10 42 70 R
ntral lobule 20 36 46 R
eus 14 44 72 L
occipital G 48 68 10 L
occipital G 52 74 4 L
llum 46 58 20 L
frontal G 26 14 52 R
r G 48 66 28 L
occipital G 38 76 26 L
r G 44 60 24 R
r G 40 52 22 R
tral G 40 6 38 R
134 J. Chumbley et al. / Neuroscience 280 (2014) 130–141parametric modulator which coded trial by trial prediction
errors. To do this, we ﬁrst used Rescorla–Wagner to
separately model the prediction error to SA and EA
outcomes, respectively denoted s and e trials. These
two learners had the same form, i.e.
gstþ1 ¼ gst þ aðx gst Þ
getþ1 ¼ get þ aðx get Þ
where for example gst is the expected value on the SA trial t
and x is the outcome of that trial. This outcome is compared
with expectation via (x gst ), i.e. the prediction error. This
prediction error (gst ) updates value expectations for the
next SA trial, t+ 1. a is an unknown learning rate, which
we ﬁxed to 0.1 and 0.3 in diﬀerent simulations. In this
way, the prediction error on every trial could be
categorized as either SA/EA and either positive/negative,
perfectly reﬂecting the factorial structure of our main
2  2 factorial analysis (see previous section). As
mentioned above, this correspondence permitted us to
simply include the four prediction error types as
parametric modulators for each of the corresponding
factorial event types. After convolving with hemodynamic
response function, we treated these parametric
modulators as covariates and repeated the analyses
discussed above.
DNA analysis
After the imaging session, participants were given the
Oragene DNA OG-500 self-collection kit for DNA
sampling. Genomic DNA was extracted from saliva
samples following the manufacturer’s instructions (DNA
Genotek Inc., Ontario, Canada). Genotyping was done
with Pyrosequencing on a PyroMarkID System
(Qiagen, Hilden, Germany). Primers for BDNF SNP
rs6265 were: 50-CCA TGG GAC TCT GGA GAG CG-30
(forward, 50-biotinylated), 50-TGA CTA CTG AGC ATC
ACC CTG GAC-30 (reverse), 50-CCA ACA GCT CTT
CTA TCA-30 (sequencing primer). Genotype frequencies
(Val/Val 49%, Val/Met 40%, and Met/Met 11%) were
consistent with those reported previously in Caucasian
populations (Shimizu et al., 2004; Beste et al., 2011).
The Hardy–Weinberg equilibrium was examined using
an online source [http://www.oege.org/software/hwe-
mr-calc.shtml; (Rodriguez et al., 2009)]. None of the
genotype frequencies violated Hardy–Weinberg equilib-
rium (X2 = 0.18; p> 0.05). Individuals who were homo-
zygous for the Met allele (n= 4) were merged with
heterozygous individuals (n= 14) into a group ofMet car-
riers and compared to homozygous Val carriers (n= 17).
RESULTS
Demographic and behavioral data
Subject demographic and psychometric characteristics
grouped by BDNF Val66Met genotype are presented in
Table 1. Our Met and homozygous Val samples did not
diﬀer in average age, years of education, other
psychometric scores (ADS, STAI-T, BIS/BAS, BFI) or
measures related to task’s performance (% SA gain,%
EA gain,% missed trials, mean reaction time for
incorrect and correct trials). None of the subjects had aparticularly high level of depressive or anxiety
symptoms (ADS < 17 and STAI-T < 49).
As reported previously (Ullsperger and von Cramon,
2003; Spa¨ti et al., 2014), mean reaction time for incorrect
trials was signiﬁcantly longer than for correct trials across
genotype: reaction time (mean ± SD) incorrect trials:
537 ± 130 ms, correct trials: 505 ± 127 ms,
F(1,33) = 18.3, p< 0.002; no eﬀect of genotype
(p> 0.5). Moreover, mean RT (ms) on trials following
SA feedback was longer compared to trials following EA
feedback (F(1,33) = 5.2, p< 0.03; RT post-SA feed-
back: 517.9 ± 134.7; RT post-EA feedback:
503.4 ± 124.3). Importantly, no signiﬁcant eﬀect of geno-
type (p> 0.5), or valence (p> 0.5) or geno-
type  valence (p> 0.7), genotype  attribution
(p> 0.8) or genotype  valence  attribution (p> 0.5)
interactions was found. Thus genotypes were behavior-
ally indistinguishable.Imaging data
Here we report the interaction and main eﬀects, both
between and within genotype. In parallel analyses, we
use a small-volume correction for VS then whole-brain
correction. In Table 3, we report the whole-brain
analysis of the simple eﬀects (the simple contrasts
SA–EA losses, SA–EA gains, SA gains–losses, EA
gains–losses).Valence  attribution interaction. Within-genotype.
Within-genotype, whole-brain corrected eﬀects for the
contrast (SA gains–EA gains)–(SA losses–EA losses)
are reported in Table 2. Met carriers showed three
signiﬁcant clusters in the right caudate/putamen, the
bilateral paracentral lobule/precuneus and the left
inferior occipital cortex, whereas Val/Val carriers
showed signiﬁcant activation in the right middle frontal
gyrus, the left angular/occipital gyri and the right angular
gyrus. No signiﬁcant cluster was found for the other tail
of this whole-brain analysis, i.e. the contrast (SA
losses–EA losses)–(SA gains–EA gains).Between-genotype. Whole brain: There was no
genotype diﬀerence for the interaction (SA gains–EA
gains)–(SA losses–EA losses) at the whole-brain level.
In contrast, the converse interaction contrast (SA
losses–EA losses)–(SA gains–EA gains) showed a
genotype eﬀect in the right precentral gyrus
(p= 0.002FWE_corrected Fig. 1A, Table 2) near the inferior
frontal sulcus, a region referred as the inferior frontal
junction [IFJ; (Derrfuss et al., 2004, 2012)]. Mean percent
signal change for the right IFJ is reported in Fig. 1B.
To interpret signiﬁcant interactions, we also tested
simple eﬀects. A simple eﬀect – i.e. a contrast between
just two conditions of a factorial design – can be tested
in SPM just like any other factorial eﬀect (i.e. main or
interaction eﬀect). Examination of the simple eﬀects
showed that this interaction was driven by Met carriers
having a greater contrast (SA losses–EA losses)
as compared to Val/Val subjects (right IFJ:
p< 0.05FWE_corrected, Table 3).
Table 3. BOLD response associated with BDNF Val66Met polymorphism on the simple eﬀects of valence and attribution
Cluster (voxels) T (peak) p Cluster-level Region x y z Hem
SA gains–EA gains
Met > Val/Val
404 5.42 <0.001-FWE-corrected Precuneus 16 44 56 R
Paracentral lobule 18 36 52 R
Precuneus 2 52 56 L
231 4.64 <0.01-FWE-corrected Supramarginal G 64 28 20 L
Supramarginal G 52 36 32 L
Superior Temporal G 48 40 18 L
Val/Val > Met
None
SA losses–EA losses
Met > Val/Val
174 4.66 <0.05-FWE-corrected Middle frontal G 38 14 36 R
Precentral G 44 8 38 R
Middle frontal G 50 14 44 R
Met > Val/Val
None
SA gains–SA losses
Met > Val/Val
None
Val/Val > Met
None
EA gains–EA losses
Met > Val/Val
None
Val/Val > Met
434 6.06 <0.001-FWE-corrected Superior parietal 22 50 54 L
Paracentral lobule 18 36 50 R
Precuneus 16 46 52 R
FWE, family-wise error; G, gyrus; Hem, hemisphere; L, left; R, right.
Fig. 1. Whole-brain analysis of BDNF Val66Met polymorphism eﬀect on the attribution (SA/EA)  valence (gains/losses) interaction. (A) We found
a genotype eﬀect in the right inferior frontal junction. (B) Mean percent signal change in the right inferior frontal junction for self-attributed (SA) and
externally-attributed (EA) losses and gains in Val/Val carriers (white) and Met carriers (gray).
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showed a genotype diﬀerence for the interaction
contrast (SA gains–EA gains)–(SA losses–EA losses) in
left ventral putamen (p= 0.009FWE_corrected
corresponding to a cluster of 28 voxels, t= 4.25,
x= 22, y= 10, z= 14; Fig. 2A). This signiﬁcant
three-way interaction is depicted in Fig. 2B, in terms of
mean percent signal change. The other tail of this
interaction eﬀect, i.e. (SA losses–EA losses)–(SA
gains–EA gains), was not signiﬁcant anywhere within
the mask.
Examination of the simple eﬀects showed that this
interaction was driven by Met carriers showing a greater
contrast (SA gains–SA losses) as compared to Val/Val
subjects (in the left and right ventral putamen (left
putamen: p< 0.02FWE_corrected corresponding to a
cluster of 19 voxels, t= 3.89, x= 24, y= 8, z= 14;
right putamen: p< 0.03FWE_corrected corresponding to a
cluster of 10 voxels, t= 3.80, x= 26, y= 10, z= 16).
No signiﬁcant eﬀects were found for the contrasts (EA
gains–EA losses), (SA gains–EA gains) and (SA losses–
EA losses).
Valence main eﬀect. Within-genotype. Whole
Brain: For the contrast Gains–Losses, Val/Val carriersFig. 2. Small-volume corrected analysis of BDNF Val66Met poly-
morphism eﬀect on the attribution (SA/EA)  valence (gains/losses)
interaction in the ventral striatum. (A) We found a genotype eﬀect in
the left ventral putamen. (B) Mean percent signal change in the left
ventral putamen for self-attributed (SA) and externally-attributed (EA)
losses and gains in Val/Val carriers (white) and Met carriers (gray).showed signiﬁcant bilateral VS (caudate/putamen)
activation and numerous signiﬁcant regions in the
occipital/calcarine gyri, supplementary motor area/
superior frontal cortex, parahippocampal gyrus, superior
parietal cortex. Analogous activations were found in Met
carriers. For the contrast Losses–Gains, activation in the
medial superior frontal cortex was found in Val/Val
subjects and in the left inferior frontal cortex pars orbitalis
and triangularis in Met Carriers. There was no evidence
for the contrast Losses–Gains in either genotype.
Between-genotype. No statistical genotype diﬀerence
was found at the whole-brain level or with the small-
volume corrected analysis.
Agency main eﬀect. Within-genotype. Whole
brain: For the contrast SA–EA feedback, Val/Val carriers
showed a signiﬁcant activation in the left caudate, Met
carrier activations were in the dorsal anterior cingulate
cortex and the midbrain extending into the thalamus.
For the contrast EA–SA feedback, Val/Val carriers that
showed numerous bilateral activations were found in the
superior and middle frontal cortex, the postcentral gyrus/
superior parietal lobule and posterior cingulate cortex,
the angular gyrus, the right middle and inferior temporal
cortex temporal pole and parahippocampal areas and
the left cerebellum consistent with previous results
(Spa¨ti et al., 2014). Analogous activations were found in
Met carriers.
Between-genotype. No statistical genotype diﬀerence
was found at the whole-brain level or with the small-
volume corrected analysis.
Model-based prediction error
The genotype  valence  attribution interaction eﬀects
described above remain signiﬁcant when the prediction
error for the four feedback conditions were included as
covariates. This indicated that they could not be
accounted for by these prediction error covariates. We
observed no signiﬁcant eﬀect of genotype on the
condition-speciﬁc scaling of prediction errors
themselves. Thus all interesting variance appears to
have been captured by a qualitative comparison of our
factorial conditions.
Correlation between BOLD response and BAS-drive
scores
Simple regression analysis of mean percent signal
change in the ventral putamen (reported in Fig. 2B) on
BAS scores were performed for each genotype
separately. No signiﬁcant correlation was found.
However,Val/Val carriers showedapositive correlation
between BAS scores and% signal change in right IFJ
(reported in Fig. 1B) for all four feedback conditions
separately (SA losses: r2 = 0.39, p< 0.008, EA losses:
r2 = 0.37, p< 0.001, SA gains: r2 = 0.30, p< 0.03; EA
gains: r2 = 0.39, p< 0.008). These correlations were
driven by the BAS Drive sub-score (SA losses: r2 = 0.55,
p< 0.0008, EA losses: r2 = 0.56, p< 0.0006, SA gains:
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For illustration, the scatter plot between mean percent
signal change for SA losses and BAS Drive in Val/Val and
Met carriers is reported in Fig. 3. No signiﬁcant correlation
was found in Met carriers. The stronger correlation with
the BAS-Drive is consistent with the deﬁnition of the BAS
sub-scores: BAS-Drive ‘measures an individual’s general
tendency to actively pursue reward’ in the immediate
environment, whereas BAS-gratiﬁcation ‘reﬂects the
inclination to seek out new rewarding experiences’
(Beaver et al., 2006).DISCUSSION
Our study is the ﬁrst to examine the eﬀect of BDNF
polymorphism on human VS responses to feedback
valence and attribution. We showed that BDNF Val66Met
polymorphism predicts VS responses to ﬁnancial
feedback. Speciﬁcally, we found that Met carriers’ VS
response reﬂected a signiﬁcant valence  agency
interaction while Val/Val carriers’ VS response was
relatively independent of agency (hence a signiﬁcant
genotype  valence  agency interaction). Closer
examination revealed a genotype diﬀerence strongest for
the simple contrast SA gain–SA losses. Our whole-brain
analysis showed another genotype  valence  agency
interaction eﬀect in the right IFJ. Here Val/Val carriers
showed a lower IFJ response, leading to a genotype
diﬀerence for the simple contrast SA–EA losses.
Interestingly, greater IFJ response in Val/Val carriers was
associated with higher motivation (BAS-Drive scores).
This pattern of results may arise from reduced attention
allocation/motivational salience during the processing of
SA losses in Val/Val compared toMet carriers.
The VS has previously been associated with several
processes relevant to feedback evaluation, including
signaling reward prediction error, incentive motivation,
and motivational salience (Haruno and Kawato, 2006;
Bromberg-Martin et al., 2010; Berridge, 2012). Fully dis-
entangling the contribution of these diﬀerent processes
is not within the scope of our study. However, our
model-based analyses suggest that genotype diﬀerences
in the valence  agency interaction cannot be reduced to
genotype diﬀerences in reward prediction error. One pos-
sibility is that SA trials were more salient than EA trials
due to personal responsibility (Zink et al., 2004;Fig. 3. Scatterplot showing the correlation between mean% signal change
Drive scores. (A) Val/Val carriers and (B) Met carriers.Satterthwaite et al., 2012; Studer et al., 2012), and that
salience varied between genotypes. This might be consis-
tent with other reports of higher VS activity in Met carriers
during anticipation of performance-dependent monetary
losses (but not gains) (Pecina et al., 2014). Since neural
activity in anticipation of a monetary feedback is consid-
ered to reﬂect appetitive and motivational aspects of
reward processing (rather than its hedonic value), these
ﬁndings suggest that BDNF Val66Met polymorphism inﬂu-
ences the motivational salience processing of SA losses.
As discussed below, this interpretation is also supported
by the whole-brain genotype eﬀect found in the right IFJ.
The IFJ is thought to play a major role in top-down
modulation of attention and cognitive control (Derrfuss
et al., 2005; Corbetta et al., 2008; Kim, 2014). Increased
IFJ activity has been reported across various tasks, in
which participants needed to shift attention, switch task
rules, or ﬁlter irrelevant information (Derrfuss et al.,
2004, 2005; Kim et al., 2012). Moreover, activity in the
IFJ and in the left basal ganglia (including the ventral
putamen) during a working memory task has been shown
to precede the ﬁltering of irrelevant information and to cor-
relate with working memory capacity (McNab and
Klingberg, 2008), indicating that greater IFJ response is
associated with better performance. We found that Val/Val
carriers showed lower IFJ activity across all feedback
conditions except EA losses (Fig. 1B). Our observation that
Val/Val carriers’ IJF responded more to EA losses than to
other types of feedback, invites the speculation (reverse
inference) that these EA losses engage more top-down
attentional resources in these subjects. It is notable that
genotype diﬀerences in IFJ were speciﬁc to SA losses,
mirroring the genotype eﬀect in the ventral putamen.
Overall these results may suggest that BDNF Val66Met
polymorphism modulates attentional processes that
inﬂuence the perceived motivational salience of SA negative
feedback.
Our interpretation of imaging results in VS and IFJ as
reduced attention and motivational salience seems
reasonable in light of recent ﬁndings on the role of
motivation in attentional deployment [see (Engelmann
et al., 2009; Pessoa and Engelmann, 2010)]. Several
lines of evidence indicate that motivation and reward sig-
nals are integrated in sensory and cognitive control
regions [reviewed by (Pessoa and Engelmann, 2010)].
We found that, across all feedback conditions, greaterfor self-attributed losses in the right inferior frontal junction and BAS
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[operationalized via the BAS-Drive scores, (Beaver et al.,
2006)] in Val/Val carriers. This result is consistent with
previous ﬁndings showing that incentive value modulates
activity in fronto-parietal attentional regions, including the
IFJ, and that individual IFJ activity was also predictable
from BAS-Drive scores (Engelmann et al., 2009). The
frontal lobe receives widespread dopaminergic projec-
tions from the midbrain and the VS, regions that poten-
tially mediate individual diﬀerences in motivational
salience (Bromberg-Martin et al., 2010; Berridge, 2012).
This suggests that ‘‘dopaminergic neuromodulation may
be a key mechanism by which motivation sharpens atten-
tion and behavioral performance’’ (Pessoa and
Engelmann, 2010). Recent evidence shows that BDNF
Val66Met polymorphism inﬂuences dopaminergic trans-
mission in the VS (Pecina et al., 2014), and thus poten-
tially also in fronto-striatal circuits. This might provide a
mechanism by which the BDNF genotype may inﬂuence
attentional and motivational processes.
Higher IFJ activity has previously been related to
higher incentive value and better performance during
tasks requiring top-down modulation of attention and
cognitive control (McNab and Klingberg, 2008;
Engelmann et al., 2009). In our study, task diﬃculty was
manipulated and groups were matched for performance,
thus we could not assess whether lower IFJ activity in
Val/Val subjects was related to lower absolute perfor-
mance. In general, the literature is inconsistent about
BDNF Val66Met performance deﬁcits: a recent meta-
analysis found no clear associations between BDNF
Val66Met polymorphism and speciﬁc cognitive pheno-
types (Mandelman and Grigorenko, 2012). As Mandel-
man and Grigorenko point out, several reasons may
contribute to the apparent inconsistencies. These include
a failure to group studies by similarities in the brain activa-
tion pathways that underlie the cognitive phenotype,
rather than behavioral similarities. Furthermore, eﬀects
of stratiﬁcation by demographic characteristics could also
be important. For example, a 10-year follow-up study
showed a faster decline in task-switching performance
in Val/Val compared to Met carriers (Erickson et al.,
2008), suggesting that behavioral deﬁcits in Val/Val com-
pared to Met carriers may have been more easily
detected using IFJ-dependent cognitive tasks and in
elderly subjects. This hypothesis is consistent with previ-
ous studies in healthy elderly subjects reporting behav-
ioral deﬁcits in Val/Val compared to Met carriers in
cognitive tasks known to engage the IFJ, including the
Stroop interference, auditory distraction and task-switch-
ing paradigms (Harris et al., 2006; Erickson et al., 2008;
Gajewski et al., 2012; Getzmann et al., 2013).
Our genotypeeﬀectmaysuggest a routeof vulnerability
to MDD. We have recently observed that, compared to
healthy controls, unmedicated depressed patients show a
VS response modulated by valence but relatively
insensitive to agency. This eﬀect was also associated
with an increased VS response to SA losses (Spa¨ti et al.,
unpublished observation), similar to our ﬁndings in Val/
Val carriers. This may be relevant because altered striatal
responses to performance-dependent monetary losseshave been reported in healthy adolescents at risk for
anxiety disorder (Chronis-Tuscano et al., 2009;
Helﬁnstein et al., 2011). Since trait anxiety andneuroticism,
known risk factors for MDD, are also reportedly higher in
Val/Val compared to Met carriers (Sen et al., 2003; Lang
et al., 2005; Hunnerkopf et al., 2007; Frustaci et al.,
2008), these results encourage speculation that altered
motivational salience processing of SA losses may repre-
sent vulnerability to MDD.
Our study has some limitations. First, our sample size
was relatively small. Second, feedback agency in our task
required subjects to attend closely to trial-by-trial agency
information, which was presented just before feedback.
It is possible that genotypes diﬀered in their ability to
perform this basic discrimination and/or that diﬀerential
IFJ activity reﬂected impaired discrimination. Speaking
against this, both genotypes showed behavioral
evidence of discrimination, i.e. longer reaction times for
trials following a SA feedback compared to an EA
feedback. Furthermore, we found no signiﬁcant
genotype diﬀerence in BOLD sensitivity to attribution per
se (i.e. EA versus SA feedback), and participants did
not report diﬃculty in understanding agency during
debrieﬁng. A third limitation of our study is that task
diﬃculty was under experimental control so that we
cannot assess whether IFJ is associated with poorer
performance. Finally, our task is not optimal for
addressing one key distinction in the feedback
processing literature. Speciﬁcally, it has been proposed
that the right IFJ can operate in both ‘proactive’ and
‘reactive’ modes of cognitive control, partly depending
on whether subjects are anticipating ﬁnancial reward or
reacting to ﬁnancial penalty (Locke and Braver, 2008;
Braver et al., 2009). While we found no evidence of a
genotype eﬀect on the IFJ temporal dynamics across
feedback conditions, our task was not designed to inves-
tigate proactive and reactive cognitive control processes.CONCLUSION
We found that BDNF Val66Met polymorphism predicts
how feedback valence and agency information are
combined in the VS and IFJ. This genotype eﬀect seems
to partly reduce to diﬀerent responses to SA ﬁnancial
losses. Compared to Met, Val/Val carriers showed a
lower IFJ response and an increased VS response to SA
losses. Moreover, in Val/Val carriers greater IFJ activity
was associated with higher BAS-Drive scores. These
results may point to a reduced allocation of attentional
resources to, and altered motivational salience of SA
losses in Val/Val compared to Met carriers.CONFLICT OF INTEREST
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